Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
Scar formation after palatoplasty is considered to inhibit maxillary growth and dento-alveolar development. Transforming growth factor-β1 (TGF-β1) reportedly causes the differentiation of fibroblasts toward cells possessing a contractile phenotype (myofibroblasts) during wound-healing. The aim of this study is to clarify the mechanism underlying the activation of TGF-β1 in efforts to identify promising pharmacological approaches for the suppression of scar formation. As a result, a TGFβ type I receptor inhibitor appears to be effective in inhibiting the myofibroblastic differentiation, and may be a possible therapeutic approach for the suppression of scar formation.
|